Indian Diazepam Exporters: Complete Supplier Ranking with Market Share — 75 Manufacturers (2026) — TransData Nexus

Q: Who is the largest diazepam supplier from India?

VENOR PHARMA LIMITED is the largest diazepam exporter from India with a 18.4% market share and export value of $1.4M.

Q: How many diazepam suppliers are there in India?

There are 75 active diazepam exporters in India, collectively shipping $7.5M worth of diazepam across 534 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top diazepam suppliers from India?

The top 5 diazepam suppliers from India — VENOR PHARMA LIMITED, MYLAN LABORATORIES LIMITED, GLAND PHARMA LTD, CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED, SWISS PARENTERALS LIMITED — together control 56.4% of total diazepam export value from India.

Suresh Sormare

Diazepam

India Pharmaceutical Trade Intelligence

$7.5M75 Suppliers77 CountriesHS 30049099

ExportsIndia → UNITED STATES32.2%India → TANZANIA6.7%

ImportsUNITED STATES → India$1.5M CANADA → India$5.3K

#1 Supplier: VENOR PHARMA

Diazepam Suppliers from India (2026) — 75 Exporters, $7.5M Market | TransData Nexus | TransData Nexus

Who Exports Diazepam from India — 75 Suppliers Behind a $7.5M Market

India's diazepam export market is supplied by 75 active exporters who collectively shipped $7.5M across 534 shipments. VENOR PHARMA LIMITED leads with a 18.4% market share, followed by MYLAN LABORATORIES LIMITED and GLAND PHARMA LTD. The top 5 suppliers together control 56.4% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published March 2026·

India's Top Diazepam Suppliers & Exporters — 75 manufacturers, $7.5M export market, top destinations and formulations — Diazepam supplier data — 75 exporters · $7.5M market · 534 shipmentsTransData Nexus · Indian Customs Data

Top Diazepam Exporters from India — Ranked by Export Value

VENOR PHARMA LIMITED is the leading diazepam exporter from India, holding a 18.4% share of the $7.5M market across 534 shipments from 75 exporters. The top 5 suppliers — VENOR PHARMA LIMITED, MYLAN LABORATORIES LIMITED, GLAND PHARMA LTD, CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED, SWISS PARENTERALS LIMITED — collectively control 56.4% of total export value, indicating a moderately concentrated market. Individual shares are: VENOR PHARMA LIMITED (18.4%), MYLAN LABORATORIES LIMITED (16.8%), GLAND PHARMA LTD (11.1%), CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED (5.2%), SWISS PARENTERALS LIMITED (4.9%).

Top Diazepam Exporters from India

Ranked by export value · 75 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Diazepam Exporters from India — Ranked by Export Value. 75 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Diazepam exporters

Certification and compliance status for top Diazepam suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Mylan Laboratories Limited	Approved	Yes	Yes	Multiple	FDA-approved ANDAs; WHO-GMP certified; EU GMP compliant.
Gland Pharma Ltd	Approved	Yes	Yes	Multiple	FDA-approved ANDAs; WHO-GMP certified; EU GMP compliant.
Swiss Parenterals Limited	Not Listed	Yes	No	Not verified	WHO-GMP certified; no FDA or EU GMP listings found.
Bharat Parenterals Limited	Not Listed	Yes	No	Not verified	WHO-GMP certified; no FDA or EU GMP listings found.
Ultra Laboratories Pvt Ltd	Not Listed	Yes	No	Not verified	WHO-GMP certified; no FDA or EU GMP listings found.

TransData Nexus reviewed the regulatory standing of 5 leading Diazepam exporters from India. 2 hold US FDA facility approvals, 5 maintain WHO-GMP certification, and 2 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Diazepam sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for Active Pharmaceutical Ingredients (APIs) production. The city hosts over 800 pharmaceutical companies, including major players like Dr. Reddy's Laboratories and Aurobindo Pharma. Its advanced R&D infrastructure and skilled workforce make it a prime location for sourcing high-quality APIs, such as Diazepam.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its expertise in pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production, with companies like Zydus Cadila and Torrent Pharmaceuticals leading the sector. This region's strong regulatory compliance and infrastructure support make it ideal for manufacturing Diazepam formulations.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceuticals. Mumbai, being India's financial capital, offers robust logistics and port facilities, facilitating efficient international distribution. Companies like Cipla, headquartered in Mumbai, leverage this infrastructure to export products like Diazepam to global markets.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Diazepam exporters from India

October 2023

Divestiture

Viatris Inc. (formerly Mylan Laboratories Limited) — Viatris divests non-core businesses for $3.6 billion

In October 2023, Viatris reached agreements to divest nearly all of its over-the-counter (OTC) business, women's healthcare business, and India-based active pharmaceutical ingredients (API) business for approximately $3.6 billion. - IMPACT: This divestiture may lead to a strategic refocus on core pharmaceutical products, potentially affecting Diazepam production and export strategies.

Impact: This divestiture may lead to a strategic refocus on core pharmaceutical products, potentially affecting Diazepam production and export strategies.

December 2024

Regulatory Action

Viatris Inc. (formerly Mylan Laboratories Limited) — FDA issues warning letter to Viatris' Indore facility

In December 2024, the U.S. Food and Drug Administration (FDA) issued a warning letter and import alert concerning Viatris' manufacturing facility in Indore, India. The alert affects 11 actively distributed products, which will no longer be accepted into the U.S. until the warning is lifted. - IMPACT: This regulatory action could disrupt Diazepam exports from this facility, potentially impacting supply chains and market availability.

Impact: This regulatory action could disrupt Diazepam exports from this facility, potentially impacting supply chains and market availability.

Common Questions — Diazepam Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which diazepam supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, VENOR PHARMA LIMITED leads with 98 recorded shipments worth $1.4M. MYLAN LABORATORIES LIMITED (28 shipments) and GLAND PHARMA LTD (4 shipments) are also established high-volume exporters.

Q How many diazepam manufacturers are there in India?

India has 75 active diazepam exporters with a combined export market of $7.5M across 534 shipments to 77 countries. The top 5 suppliers hold 56.4% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for diazepam from India?

Average FOB unit price: $11.12 per unit, ranging from $0.00 to $355.01. Average shipment value: $14.0K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Diazepam

Diazepam

Who Exports Diazepam from India — 75 Suppliers Behind a $7.5M Market

Top Diazepam Exporters from India — Ranked by Export Value

Top Diazepam Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Viatris Inc. (formerly Mylan Laboratories Limited) — Viatris divests non-core businesses for $3.6 billion

Viatris Inc. (formerly Mylan Laboratories Limited) — FDA issues warning letter to Viatris' Indore facility

Common Questions — Diazepam Suppliers from India

Q Which diazepam supplier from India is the most reliable for bulk orders?

Q How many diazepam manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for diazepam from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

CSL Limited — CSL completes $11.7 billion acquisition of Vifor Pharma

Analysis Methodology